Treating Depression (and Other Disorders) with Psychedelic Drugs

Researchers in The Depression Evaluation Service (DES) at New York State Psychiatric Institute and Columbia’s Department of Psychiatry are working on innovative studies using psilocybin and other psychedelic compounds in treatment of psychiatric symptoms and disorders. These long-neglected compounds may provide breakthroughs in treating a wide range of psychiatric disorders.